日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.

肥大细胞衍生的神经生长因子驱动 ILC2 在膀胱癌中发挥促肿瘤功能。

Falquet Maryline, El Ahanidi Hajar, Gomez-Cadena Alejandra, Su Ziyang, Cornu Anthony, Wyss Tania, Kizil Burak, Pick Robert, Falamaki Katayoun, Wirapati Pratyaksha, Fiordi Benedetta, Senoner Isis, Maresca Daniela Claudia, Kallal Neil, Guedj Danaé, Kreutzfeldt Mario, Tille Jean-Christophe, Leblond Marine M, Michaud Katarzyna, Pesce Silvia, Candiani Simona, Golebski Korneliusz, Dagher Julien, Charrier Melinda, Pressacco Brossier Caroline, Grobet-Jeandin Elisabeth, Marone Romina, Hugues Stéphanie, Jeker Lukas T, Verdeil Grégory, Merkler Doron, Marcenaro Emanuela, Scheiermann Christoph, Attaleb Mohammed, Benamran Daniel, Tsantoulis Petros, Ercolano Giuseppe, Trabanelli Sara, Jandus Camilla

Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study

三甲胺N-氧化物(TMAO)用于急性缺血性卒中后风险分层:来自BIOSIGNAL队列研究的结果

Frenger, Johannes; Jeker, Benjamin; Arnold, Markus; Grosse, Gerrit M; Pokorny, Thomas; Westphal, Laura P; Inauen, Corinne; Bicciato, Giulio; Arnold, Marcel; Fischer, Urs; De Marchis, Gian Marco; Kägi, Georg; Kahles, Timo; Cereda, Carlo W; Bustamante, Alejandro; Montaner, Joan; Ntaios, George; Foerch, Christian; Spanaus, Katharina; von Eckardstein, Arnold; Mueller, Daniel; Katan, Mira

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study

伊达卡巴基因维克鲁塞尔或西他卡巴基因自体白细胞介素治疗复发或难治性多发性骨髓瘤:一项国际多中心研究

Merz, Maximilian; Albici, Anca-Maria; von Tresckow, Bastian; Rathje, Kristin; Fenk, Roland; Holderried, Tobias; Müller, Fabian; Tovar, Natalia; Oliver-Cáldes, Aina; Vucinic, Vladan; Kharboutli, Soraya; Bärmann, Ben-Niklas; Ayuk, Francis; Platzbecker, Uwe; Stölzel, Friedrich; Schub, Nathalie; Schmitz, Friederike; Fandrei, David; Born, Patrick; Khandanpour, Cyrus; Hanoun, Christine; Hörster, Keven; Teichert, Marcel; Jeker, Barbara; Hoffmann, Michele; Kröger, Nicolaus; de Larrea, Carlos Fernández; Pabst, Thomas; Gagelmann, Nico

Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial

比较干细胞动员联合化疗和细胞因子(G-CSF)与单独使用细胞因子治疗多发性骨髓瘤患者的疗效(MOCCCA):一项随机、开放标签、非劣效性 II 期试验

Jeker, Barbara; Thalmann, Laura; Bacher, Ulrike; Nilius, Henning; Rhyner, Gaëlle; Sökler, Martin; Soltermann, Susanne; Winkler, Annette; Vorburger, Corinne; Daskalakis, Michael; Hoffmann, Michèle; Pabst, Thomas

Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study

三甲胺N-氧化物(TMAO)用于急性缺血性卒中后风险分层:来自BIOSIGNAL队列研究的结果

Frenger, Johannes; Jeker, Benjamin; Arnold, Markus; Grosse, Gerrit M; Pokorny, Thomas; Westphal, Laura P; Inauen, Corinne; Bicciato, Giulio; Arnold, Marcel; Fischer, Urs; De Marchis, Gian Marco; Kägi, Georg; Kahles, Timo; Cereda, Carlo W; Bustamante, Alejandro; Montaner, Joan; Ntaios, George; Foerch, Christian; Spanaus, Katharina; von Eckardstein, Arnold; Mueller, Daniel; Katan, Mira

Adherence to Multidisciplinary Tumor Board Recommendations in Patients with Multiple Myeloma

多发性骨髓瘤患者对多学科肿瘤委员会建议的遵循情况

Gennheimer, Valérie; Akhoundova, Dilara; Hoffmann, Michèle; Jeker, Barbara; Banz, Yara; Bacher, Ulrike; Pabst, Thomas

Elranatamab for Relapsed/Refractory Multiple Myeloma With Severe Renal Impairment Requiring Hemodialysis

Elranatamab 用于治疗复发/难治性多发性骨髓瘤伴严重肾功能损害(需血液透析)

Hoffmann, Michèle; Jeker, Barbara; Huynh-Do, Uyen; Banz, Yara; Godau, Jeanne; Weber, Elisabeth; Bacher, Ulrike; Pabst, Thomas

CAR T-Cell Therapies for Patients With Relapsed and Refractory Aggressive Lymphomas: Real-World Experiences From a Single Center on the Use of Radiotherapy

CAR-T细胞疗法治疗复发难治性侵袭性淋巴瘤患者:来自单一中心放射治疗应用的真实世界经验

Jutzi, J T; Wampfler, J; Ionescu, C; Kronig, M N; Jeker, B; Hoffmann, M; Reusser, I; Haslebacher, C; Sendi Stamm, S; Schletti, M; Lüscher, B P; Bacher, V U; Wehrli, M; Daskalakis, M; Pabst, T; Novak, U

Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy

靶向BCMA或GPRC5D的双特异性抗体在CAR-T细胞疗法后复发的多发性骨髓瘤中疗效显著。

Merz, Maximilian; Dima, Danai; Hashmi, Hamza; Ahmed, Nausheen; Stölzel, Friedrich; Holderried, Tobias A W; Fenk, Roland; Müller, Fabian; Tovar, Natalia; Oliver-Cáldes, Aina; Rathje, Kristin; Davis, James A; Fandrei, David; Vucinic, Vladan; Kharboutli, Soraya; Baermann, Ben-Niklas; Ayuk, Francis; Platzbecker, Uwe; Albici, Anca-Maria; Schub, Nathalie; Schmitz, Friederike; Shune, Leyla; Khouri, Jack; Anwer, Faiz; Raza, Shahzad; McGuirk, Joseph; Mahmoudjafari, Zahra; Green, Kimberly; Khandanpour, Cyrus; Teichert, Marcel; Jeker, Barbara; Hoffmann, Michele; Kröger, Nicolaus; von Tresckow, Bastian; de Larrea, Carlos Fernández; Pabst, Thomas; Abdallah, Al-Ola; Gagelmann, Nico

Gender-Specific Prognostic Impact of Treosulfan Levels in High-Dose Chemotherapy for Multiple Myeloma

多发性骨髓瘤高剂量化疗中曲奥舒凡水平的性别特异性预后影响

Heini, Alexander D; Kammermann, Karin; Bacher, Ulrike; Jeker, Barbara; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Nilius, Henning; Pabst, Thomas